TEL: (+62) 21 5890 1590
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Patients seek consultations for various reasons. However, there is a new common factor that influences people’s decision to get a cosmetic treatment: social media. A person with social media dysmorphia (SMD), or selfie or Snapchat dysmorphia, may have a body dysmorphic disorder (BDD) that can be triggered or worsened by social media.
Many social media users are accustomed to sharing selfies that have been altered with filters to erase imperfections. Constant exposure to this enhanced version of oneself—combined with the positive feedback in the form of likes, shares, and follows—can make people feel their unedited selves aren’t enough. Some potential patients may even present a modified selfie to demonstrate aesthetic goals, regardless of whether or not they are realistic.
While social media dysmorphia isn’t a recognized diagnosis per the DSM-5, the term still reflects the way that social media can impact someone with BDD. A person with BDD is usually obsessed with self-perceived flaws that others likely do not notice. Too often, this psychological disorder is mis- or undiagnosed.
While social media doesn’t cause BDD, it can trigger or worsen it. Teenagers and influencers are often at higher risk for developing BDD because of their excessive use. Influencers may perceive their market value to directly correlate to the number and quality of their social media interactions.
There is a clear connection between social media use and demand for cosmetic enhancements. In fact, more than half of aesthetic surgeons say they’ve seen an increase in the number of patients who want treatments specifically to improve their selfies. However, it’s important to screen prospective patients for SMD and BDD for a number of reasons:
Researchers estimate that up to 15% of patients seeking cosmetic enhancement procedures have BDD, the majority of whom are women. Because SMD is a relatively new development, however, it isn’t clear yet how many people have it.
Symptoms of BDD include:
While it can be difficult to determine whether a patient’s perception of his or her flaws is warranted, medical aesthetic experts should screen clients for possible mental health concerns prior to administering treatment. One survey found that 84% of aesthetic practitioners had treated a person they considered an appropriate candidate and later determined that the recipient had BDD.
To better identify patients who may have BDD and/or social media dysmorphia, pay attention to their concerns. If someone presents edited selfies during a consultation, ask how much the pictures been edited. Be clear and firm about what aesthetic treatment can and can’t do. You can also ask a candidate to identify flaws in a mirror. This could help you get a better sense of his or her self-perception.
Another way to screen for BDD is to use a questionnaire that lists common symptoms. Have patients rate the severity of distress for each one. If a person has symptoms of BDD, you can then refer them to a mental health specialist.
Before treating any patient, you should address these questions:
With social media playing an ever-increasing role in people’s lives, it is imperative to keep BDD and SMD in mind during each consultation. To avoid dramatic surgical outcomes that may not be reversible, consider providing non-invasive solutions to better serve your patients.
Venus Concept offers an extensive lineup of cutting-edge, non-invasive medical aesthetic devices and post-sales support services. Contact us today for more information or download our report, “Filters and Fillers: The Growing Incidence of Social Media Dysmorphia in the Medical Aesthetics Space.”
For more information call: (+62 21) 5890 1590 // info.id@venusconcept.com // Ruko Business Park Kebon Jeruk Blok B11 Jl. Meruya Ilir Raya No. 88 Kel. Meruya Utara, Kec. Kembangan West Jakarta 11620
REGULATORY CLEARANCES [ More ]
All devices have received Indonesian Health Ministry Approval for sale and use in Indonesia. (Izin Edar Alat Kesehatan)
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Viva™ is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for the treatment of moderate to severe wrinkles and rhytides in Fitzpatrick skin types I-IV.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of stretch marks at the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2018 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here